HIIFS
BBH icon

Harel Insurance Investments & Financial Services’s VanEck Biotech ETF BBH Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-980
Closed -$105K – 423
2016
Q4 		$105K Buy
980
+200
+26% +$21.8K 0.01% 148
2016
Q3 		$90K Hold
780
– – 0.01% 166
2016
Q2 		$80K Buy
+780
New +$83.2K 0.01% 272
2016
Q1 		– Sell
-830
Closed -$86.6K – 181
2015
Q4 		$105K Buy
+830
New +$102K 0.01% 142

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Harel Insurance Investments & Financial Services's BBH Position: Q1 2017 in Review

Harel Insurance Investments & Financial Services sold out of VanEck Biotech ETF (BBH) in Q1 2017, closing a stake of 980 shares — an estimated $105K sold.

Harel Insurance Investments & Financial Services first reported a position in BBH in Q4 2015 and held it in 4 quarters. The position peaked at $105K in Q4 2016. 79 funds tracked by Wall St. Rank hold BBH as of Q1 2017.

  • Harel Insurance Investments & Financial Services reported no remaining VanEck Biotech ETF position as of Q1 2017 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 980 VanEck Biotech ETF shares in Q1 2017, an estimated $105K.
  • Harel Insurance Investments & Financial Services first reported a position in VanEck Biotech ETF in Q4 2015 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's VanEck Biotech ETF position peaked at $105K in Q4 2016.
  • 79 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2017.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2017, filed 8 May 2017.